0001104659-21-098422.txt : 20210730
0001104659-21-098422.hdr.sgml : 20210730
20210730201744
ACCESSION NUMBER: 0001104659-21-098422
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210728
FILED AS OF DATE: 20210730
DATE AS OF CHANGE: 20210730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dalton Lisa
CENTRAL INDEX KEY: 0001732196
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 211134239
MAIL ADDRESS:
STREET 1: 3737 MARKET STREET, SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
tm2123737-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-07-28
0
0001641640
Nabriva Therapeutics plc
NBRV
0001732196
Dalton Lisa
414 COMMERCE DRIVE
SUITE 120
FORT WASHINGTON
PA
19034
1
0
0
0
Ordinary Shares
2021-07-28
4
A
0
17500
0
A
17500
D
Share Options
1.08
2021-07-28
4
A
0
35500
0
A
2031-07-27
Ordinary Shares
35500
35500
D
The reported transaction involved the reporting person's receipt of a grant of 17,500 restricted stock units. The total reported in Column 5 includes the 17,500 newly awarded restricted stock units.
The option was granted on July 28, 2021.
One hundred percent (100%) of the option will vest on July 31, 2022, subject to the reporting person's continued service on the board of directors of Nabriva Therapeutics plc.
/s/ Robert Crotty, by power of attorney
2021-07-30